ANITA BUCKNER: Open Payments
NPI 1073175303 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,549 in 95 payments from 18 companies in 2025. Trend: 2023 $13 · 2024 $214 · 2025 $1,549
Food & beverage: $1,530Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $346 |
| ABBVIE INC. | 26 | $258 |
| Novo Nordisk Inc | 12 | $237 |
| GlaxoSmithKline, LLC. | 14 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $141 |
| PFIZER INC. | 6 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Antares Pharma, Inc. | 2 | $33 |
Products named: Ozempic, AIRSUPRA, QULIPTA, BREZTRI, JARDIANCE, TRELEGY ELLIPTA, NURTEC ODT, UBRELVY.
Industry payments across MI — which companies pay providers there.
